The Korea Herald

피터빈트

Jeil Pharmaceutical spins off Jeil Health Science

By 윤정현

Published : Sept. 8, 2016 - 17:23

    • Link copied

[DISCLOSURE] Jeil Pharmaceutical (002620) announced on Sept. 8 that it will spin off its non-prescription medicine business division.

The new company, Jeil Health Science, will be devoted to developing new over-the-counter drugs. 

Jeil Pharmaceutical will remain a public company and continue managing prescription medicine brands. The due date is Nov. 11.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)